JP2024517335A5 - - Google Patents
Info
- Publication number
- JP2024517335A5 JP2024517335A5 JP2023570090A JP2023570090A JP2024517335A5 JP 2024517335 A5 JP2024517335 A5 JP 2024517335A5 JP 2023570090 A JP2023570090 A JP 2023570090A JP 2023570090 A JP2023570090 A JP 2023570090A JP 2024517335 A5 JP2024517335 A5 JP 2024517335A5
- Authority
- JP
- Japan
- Prior art keywords
- bupropion
- nicotine
- zonisamide
- administering
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163187001P | 2021-05-11 | 2021-05-11 | |
| US63/187,001 | 2021-05-11 | ||
| PCT/US2022/028504 WO2022240819A1 (en) | 2021-05-11 | 2022-05-10 | Combination treatment methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517335A JP2024517335A (ja) | 2024-04-19 |
| JP2024517335A5 true JP2024517335A5 (https=) | 2025-05-19 |
Family
ID=84028804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023570090A Pending JP2024517335A (ja) | 2021-05-11 | 2022-05-10 | 組合せ治療方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250073186A1 (https=) |
| EP (1) | EP4337181A4 (https=) |
| JP (1) | JP2024517335A (https=) |
| CN (1) | CN117693335A (https=) |
| AU (1) | AU2022273620A1 (https=) |
| CA (1) | CA3218448A1 (https=) |
| WO (1) | WO2022240819A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4593814A1 (en) * | 2022-09-26 | 2025-08-06 | Rose Research Center, LLC | Combination for use in a method of preventing weight gain |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001518520A (ja) * | 1997-10-03 | 2001-10-16 | キャリー メディカル コーポレイション | ニコチンレセプターアンタゴニストおよび抗抑うつ薬または抗不安薬を含有するニコチン嗜癖を治療する組成物 |
| US20070212428A1 (en) * | 2004-06-04 | 2007-09-13 | Mood Management Sciences, Inc. | Methods and compositions for treating mood disorder |
| US7671094B2 (en) * | 2005-06-27 | 2010-03-02 | Biovail Laboratories International S.R.L. | Bupropion hydrobromide and therapeutic applications |
| KR20170077291A (ko) * | 2006-11-09 | 2017-07-05 | 오렉시젠 세러퓨틱스 인크. | 단위 용량 팩키지 |
-
2022
- 2022-05-10 US US18/559,872 patent/US20250073186A1/en active Pending
- 2022-05-10 CN CN202280044354.9A patent/CN117693335A/zh active Pending
- 2022-05-10 AU AU2022273620A patent/AU2022273620A1/en active Pending
- 2022-05-10 CA CA3218448A patent/CA3218448A1/en active Pending
- 2022-05-10 JP JP2023570090A patent/JP2024517335A/ja active Pending
- 2022-05-10 EP EP22808167.5A patent/EP4337181A4/en active Pending
- 2022-05-10 WO PCT/US2022/028504 patent/WO2022240819A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003243074B2 (en) | A buffered, liquid nicotine composition for pulmonary administration | |
| US8642627B2 (en) | Formulation and use thereof | |
| JP2013520408A (ja) | ニコチン含有ソフトゼラチントローチ | |
| JP2023551426A (ja) | 急速注入組成物及び方法 | |
| Molander et al. | Reduction of tobacco withdrawal symptoms with a sublingual nicotine tablet: a placebo controlled study | |
| Glover et al. | A multicenter phase 3 trial of lobeline sulfate for smoking cessation | |
| Stack | Smoking cessation: an overview of treatment options with a focus on varenicline | |
| PL196334B1 (pl) | Zastosowanie agonistów receptorów GABA B i ich farmaceutycznie dopuszczalnych pochodnych w terapii abstynencji nikotynowej u uzależnionych od nikotyny pacjentów | |
| US20100113453A1 (en) | Sublingual Formulations of D-Cycloserine and Methods of Using Same | |
| JP2024517335A5 (https=) | ||
| Frishman | Smoking cessation pharmacotherapy | |
| KR20020075795A (ko) | 흡연을 감소시키거나 또는 제거하는 방법 | |
| Bittoun | A combination nicotine replacement therapy (NRT) algorithm for hard-to-treat smokers | |
| Prignot | Pharmacological approach to smoking cessation | |
| US20250073186A1 (en) | Combination treatment methods | |
| HUE034190T2 (en) | Linaclitaxel for the treatment of chronic constipation | |
| RU2572720C1 (ru) | Комплексное антиникотиновое средство | |
| US3989823A (en) | Compositions for combating nicotinism in man | |
| AU1045695A (en) | Use of lobeline for the treatment of nicotine withdrawal | |
| WO1995011678A9 (en) | Use of nicotine substitutes for the treatment of nicotine withdrawal | |
| WO2024073334A1 (en) | Combination for use in a method of preventing weight gain | |
| TW574037B (en) | Nicotine addiction treatment | |
| Chen et al. | Special Topics in Smoking Cessation: Patients with Cardiovascular Disease and Updates on E-Cigarettes. | |
| Feret et al. | Varenicline: An oral partial nicotine agonist for smoking cessation | |
| Rose et al. | Nicotine replacement therapies and other nicotinic strategies |